# Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism

> **NCT00872898** · PHASE2 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 124 (actual)

## Conditions studied

- Autism

## Interventions

- **DRUG:** Memantine - Extended Release (ER)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00872898
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-08
- **Final completion:** —
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2014-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00872898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00872898, "Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00872898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*